Mostrar el registro sencillo del ítem
dc.contributor.author
Ridruejo, Ezequiel
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.contributor.author
Soza, Alejandro M. D.
dc.date.available
2021-02-25T18:11:57Z
dc.date.issued
2019-03-04
dc.identifier.citation
Ridruejo, Ezequiel; Soza, Alejandro M. D.; Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?; John Wiley & Sons Inc; Clinical Liver Disease; 13; 2; 4-3-2019; 43-45
dc.identifier.issn
2046-2484
dc.identifier.uri
http://hdl.handle.net/11336/126656
dc.description.abstract
Hepatitis C virus (HCV) infection is a global health concern with an estimated worldwide disease prevalence rate of 1%, meaning 71 million individuals are infected.1 In the United States, the estimated prevalence rate is 0.7%, or 7 million individuals.1 Specifically in Latin America, estimations suggest that only 25% of individuals with suspected HCV infection have been diagnosed, and only 4% received treatment.2 Recent availability in this region of directacting antivirals (DAAs), which are safer and more effective than the interferon-based therapies, may influence treatment paradigms at country levels.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
John Wiley & Sons Inc
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
HEPATITIS C
dc.subject
ERRADICATION
dc.subject
LATIN AMERICA
dc.subject
TREATMENT
dc.subject.classification
Gastroenterología y Hepatología
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
Medicina Clínica
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.title
Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2020-11-11T15:55:15Z
dc.journal.volume
13
dc.journal.number
2
dc.journal.pagination
43-45
dc.journal.pais
Estados Unidos
![Se ha confirmado la validez de este valor de autoridad por un usuario](/themes/CONICETDigital/images/authority_control/invisible.gif)
dc.description.fil
Fil: Ridruejo, Ezequiel. Hospital Universitario Austral; Argentina. Latin American Liver Research, Educational and Awareness Network; Argentina. Centro de Educación Médica e Investigaciones Clínicas "Norberto Quirno"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Soza, Alejandro M. D.. Pontificia Universidad Católica de Chile; Chile
dc.journal.title
Clinical Liver Disease
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/cld.771
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://aasldpubs.onlinelibrary.wiley.com/doi/full/10.1002/cld.771
Archivos asociados